the aid library

LIST OPTIONS

Filter

4181

The dual threat of extreme weather and the COVID-19 crisis: Anticipating the impacts on food availability

Food and Agriculture Organization of the United Nations FAO (2020) C1

The COVID-19 pandemic is having a profound negative effect on the global economy and is occurring in the context of a rapidly changing climate. This year is expected to be the second hottest in recorded history. Weather forecasts for 2020 indicate a high probability that extreme weather will adverse... more

Download (211)

View PDF (395)

Improving Prison Conditions by Strengthening the Monitoring of HIV, HCV, TB and Harm Reduction (Italy)

A. Scandurra, Dr. S. Libianchi, G. Parisi Associazione Antigone; European Union (2015) C2

Mapping Report - Italy.

Download (185)

View PDF (311)

Victimization and PTSD in Ugandan Youth

Mandrup, L. & Elklit, A. Open Journal of Epidemiology (2014) CC

Background: Little is known about post-traumatic stress (PTSD) prevalence rates in community samples. This is especially true for the African continent where child-soldiers, HIV/AIDS affected and orphans have been the target for PTSD prevalence studies. Objectives: The aim of this study is to invest... more

Download (123)

View PDF (184)

HIV/AIDS treatment and care in Georgia

D. Raben; S. F. Jakobsen; J. Klinte; J.Lundgren World Health Organization (Europe); Centre for Health & Infectious Disease Research (2014) C_WHO

Evaluation report September 2014

Download (249)

View PDF (273)

Integrating Primary Care And Public Health

Bernd Rechel Eurohealth (2020) CC

There are many calls for improved integration between primary care and public health, but also sizeable obstacles to achieving this, such as differences in the ways the two sectors are organised and financed, as well as differences in education, culture and approach. This article, based on a new... more

Download (790)

View PDF (1013)

Tuberculosis Infection Prevention and Control in Ghana

Meis, M.; V. Lipke, M. Girma, et al. KNCV; CDC; USAID, et al. (2010) C1

Download (355)

View PDF (370)

Child and adolescent health in humanitarian settings: operational guide: a holistic approach for programme managers

World Health Organization WHO; Eastern Mediterranean Region (2022) C_WHO

Download (185)

View PDF (267)

B1 Perinatal and early childhood risk and protective factor and disorders: early maltreatment and exposure to violence

Susan MK Tan, Norazlin Kamal Nor, Loh Sit Fong, Suzaily Wahab, Sheila Marimuthu & Chan Lai Fong IACAPAP (2015) C1

This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws o... more

Download (753)

View PDF (953)

Promoting partner and couples HIV testing using self-test kits in Kenya

H. Thirumurthy, E. Omanga, B. Obonyo et al. (2017) C1

Download (191)

View PDF (216)

Inclusive Solidarity and the Integration of Marginalized People

The Pontifical Academy of Social Sciences (2014) C1

Final Statement

Download (335)

View PDF (446)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (370)

View PDF (631)

Humanitarian inclusion standards for older people and people with disabilities
recommended

Age and Disability Consortium CBM International, HelpAge International,and Handicap International (2018)

The Standard consists of nine key inclusion standards, and seven sets of sector-specific inclusion standards for protection – water, sanitation and hygiene, food security and livelihoods, nutrition, shelter, settlement and household items, health and education. Each standard comes with key actions... more

Download (144)

View PDF (226)

Statistical Yearbook for Asia and the Pacific 2014

United Nations Economic and Social Commission for Asia and the Pacific (2014) C2

Download (208)

View PDF (214)

Health system considerations: when influenza meets COVID-19: preparedness and response measures when COVID-19, influenza and acute respiratory infections coincide in the WHO European Region

World Health Organization WHO, Regional Office of Europe (2020) C_WHO

revised version December 2020

Download (181)

View PDF (252)

Female genital mutilation in the Middle East and North Africa

UN Children's Fund UNICEF (2020) C_UNICEF

Almost 50 million girls and women have undergone FGM in five countries in the Middle East and North Africa, accounting for one quarter of the global total

Download (265)

View PDF (374)

Addressing comorbidity between mental disorders and major noncommunicable diseases

World Health Organization WHO; Regional Office for Europe (2017) C_WHO

Reduced healthy life expectancy due to the high burden of both mental ill health and noncommunicable diseases (NCDs) is a major public health concern in the European Region. The links between mental disorders and major NCDs are well established. In clinical practice, however, mental disorders in pa... more